Magnesium hydroxide 750 microliter/mL and mineral oil 250 microliter/mL oral suspension
RxNorm 2609733

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 2609733 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Magnesium hydroxide 750 microliter/mL and mineral oil 250 microliter/mL oral suspension.

The following semantic concepts and normalized strings are associated with this clinical entity:

PT
Magnesium hydroxide 750 microliter/mL and mineral oil 250 microliter/mL oral suspension
AUI:12756276
PTGB
Magnesium hydroxide 750 microlitre/mL and mineral oil 250 microlitre/mL oral suspension
AUI:12756277
FN
Product containing precisely magnesium hydroxide 750 microliter/1 mL and mineral oil 250 microliter/1 mL conventional release oral suspension (clinical drug)
AUI:12757337

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

PT

Designated preferred name (PT):
Magnesium hydroxide 750 microliter/mL and mineral oil 250 microliter/mL oral suspension
(Atom ID: 12756276)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
Magnesium hydroxide 750 microliter/mL and mineral oil 250 microliter/mL oral suspension
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2609733
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12756276
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
PT
Designated preferred name ()
Source Code
1217552007
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
US Edition of SNOMED CT (SNOMEDCT_US)
The official name and abbreviation for the vocabulary source.
Source Version
2026_01_31
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
National Library Of Medicine, NLM is a Charter Member of SNOMED International on behalf of the U.S., National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, 1-888-FIND-NLM (1-888-346-3656), , https://support.nlm.nih.gov/support/create-case/,
Source licensing contact information.

PTGB

British preferred term (PTGB):
Magnesium hydroxide 750 microlitre/mL and mineral oil 250 microlitre/mL oral suspension
(Atom ID: 12756277)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
Magnesium hydroxide 750 microlitre/mL and mineral oil 250 microlitre/mL oral suspension
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2609733
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12756277
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
PTGB
British preferred term ()
Source Code
1217552007
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
US Edition of SNOMED CT (SNOMEDCT_US)
The official name and abbreviation for the vocabulary source.
Source Version
2026_01_31
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
National Library Of Medicine, NLM is a Charter Member of SNOMED International on behalf of the U.S., National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, 1-888-FIND-NLM (1-888-346-3656), , https://support.nlm.nih.gov/support/create-case/,
Source licensing contact information.

FN

Full form of descriptor (FN):
Product containing precisely magnesium hydroxide 750 microliter/1 mL and mineral oil 250 microliter/1 mL conventional release oral suspension (clinical drug)
(Atom ID: 12757337)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
Product containing precisely magnesium hydroxide 750 microliter/1 milliliter and mineral oil 250 microliter/1 milliliter conventional release oral suspension (clinical drug)
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2609733
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12757337
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
FN
Full form of descriptor ()
Source Code
1217552007
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
US Edition of SNOMED CT (SNOMEDCT_US)
The official name and abbreviation for the vocabulary source.
Source Version
2026_01_31
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
National Library Of Medicine, NLM is a Charter Member of SNOMED International on behalf of the U.S., National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, 1-888-FIND-NLM (1-888-346-3656), , https://support.nlm.nih.gov/support/create-case/,
Source licensing contact information.